The Complementary and Phytotherapeutic Products Ordinance (KPTPO; SR 812.212.24) provides for Asian medicinal products without indication a marketing authorisation based on a notification in accordance with article 31. The single notifications must be submitted in the form prescribed by Swissmedic according to article 41 of the KPTPO. Swissmedic provides a corresponding electronic form and has developed the HOMANT Asia software for this purpose.
As part of the periodic review of the annexes to the KPTPO, the revised annex 10 of the KPTPO (list TAS) entered into force on 1st of July 2025. The updated master data, containing the revised list TAS, is available free of charge on the Swissmedic website as an update for the HOMANT Asia software. Link to download the updated master data and for further information: